Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1262411-34-6

1262411-34-6

Post Buying Request

1262411-34-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1262411-34-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1262411-34-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,2,4,1 and 1 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1262411-34:
(9*1)+(8*2)+(7*6)+(6*2)+(5*4)+(4*1)+(3*1)+(2*3)+(1*4)=116
116 % 10 = 6
So 1262411-34-6 is a valid CAS Registry Number.

1262411-34-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-methylthiane-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names TETRAHYDRO-4-METHYL-2H-THIOPYRAN-4-CARBOXYLIC ACID

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1262411-34-6 SDS

1262411-34-6Downstream Products

1262411-34-6Relevant articles and documents

TRICYCLIC SULFONES AS ROR GAMMA MODULATORS

-

, (2018/04/27)

There are described RORγ modulators of the formula (I), and formula (II) or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for modulating RORγ activity in a cell and methods for treating a subject suffering from a disease or disorder in which the subject would therapeutically benefit from modulation of RORγ activity, for example, autoimmune and/or inflammatory disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1262411-34-6